Emerging evidence from HCC studies suggests that chronic HBV infection upregulates PD-L1 expression in the TME, potentially increasing tumor susceptibility to PD-1/PD-L1 blockade due to altered immune signaling pathways. This evidence concerns the gene CD274 and neoplasm.